<DOC>
	<DOCNO>NCT00489450</DOCNO>
	<brief_summary>This study design investigate alcohol effect SK3530 pharmacokinetics ( PKs ) safety .</brief_summary>
	<brief_title>Phase I Study Investigate Alcohol Interaction SK3530</brief_title>
	<detailed_description>This study randomize , open , single-dose , three-treatment , three-period , three-sequence , crossover study subject receive , random order , SK3530 100mg alone , 0.5g/Kg alcohol alone , SK3530 plus alcohol together . There minimum 7 day washout period treatment . The alcohol dilute 240 mL water . The content drink 1 minute less . For SK3530 metabolite measurement , plasma sample collect pre-scheduled time safety monitor study .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>age 20 50 body weight IBM Â± 20 % cardiovascular disease colorblindness weakness availability intake 0.5 g/Kg alcohol abnormal supine blood preesure</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>SK3530</keyword>
	<keyword>alcohol</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
</DOC>